Literature DB >> 30124773

Causal inference in continuous time: an example on prostate cancer therapy.

Pål Christie Ryalen1, Mats Julius Stensrud1,2, Sophie Fosså3,4,5, Kjetil Røysland1.   

Abstract

In marginal structural models (MSMs), time is traditionally treated as a discrete parameter. In survival analysis on the other hand, we study processes that develop in continuous time. Therefore, Røysland (2011. A martingale approach to continuous-time marginal structural models. Bernoulli 17, 895-915) developed the continuous-time MSMs, along with continuous-time weights. The continuous-time weights are conceptually similar to the inverse probability weights that are used in discrete time MSMs. Here, we demonstrate that continuous-time MSMs may be used in practice. First, we briefly describe the causal model assumptions using counting process notation, and we suggest how causal effect estimates can be derived by calculating continuous-time weights. Then, we describe how additive hazard models can be used to find such effect estimates. Finally, we apply this strategy to compare medium to long-term differences between the two prostate cancer treatments radical prostatectomy and radiation therapy, using data from the Norwegian Cancer Registry. In contrast to the results of a naive analysis, we find that the marginal cumulative incidence of treatment failure is similar between the strategies, accounting for the competing risk of other death.

Entities:  

Year:  2018        PMID: 30124773     DOI: 10.1093/biostatistics/kxy036

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  2 in total

1.  The additive hazard estimator is consistent for continuous-time marginal structural models.

Authors:  Pål C Ryalen; Mats J Stensrud; Kjetil Røysland
Journal:  Lifetime Data Anal       Date:  2019-02-23       Impact factor: 1.588

2.  Estimating the causal effects of multiple intermittent treatments with application to COVID-19.

Authors:  Liangyuan Hu; Fan Li; Jiayi Ji; Himanshu Joshi; Erick Scott
Journal:  ArXiv       Date:  2021-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.